New treatment promising in type 2 diabetes

	Tweet

In a study of type 2 diabetic patients, treatment with an investigational drug called liraglutide administered by injection once daily, improved control of blood sugar levels without increasing weight, European investigators report.

Commenting on his team’s findings, Dr. Sten Madsbad from Hvidovre Hospital in Denmark told Reuters Health that insulin and other anti-diabetes drugs “also improve glycemic control, but increase weight. 

The present trial is the first to demonstrate long term improvement in glycemic control with a concomitant weight loss in type 2 diabetic patients.”

Madsbad and his colleagues tested various doses of liraglutide in 193 people with type 2 diabetes, comparing the experimental treatment with either an inactive placebo or a standard drug, glimepiride.

Long-term glucose control improved in all but the lowest liraglutide dosage group, the team reports in the medical journal Diabetes Care. The improvements were seen after one week and maintained throughout the 12-week trial.

Also, there were “fewer hypoglycemic events in the liraglutide arm,” Madsbad added, meaning that the drug was less likely than the standard treatment to drive down blood sugar too far, to dangerously low levels.

Moreover, patients taking liraglutide did not gain weight, and in fact some lost weight. Body weight increased “slightly” among those taking glimepiride.

Thus the researchers conclude that the agent “shows considerable promise as a once-daily therapy in type 2 diabetes.”

SOURCE: Diabetes Care, June 2004. 

RELATED STORIES:
World’s first stem cell bank opens   Food additive prevents pre-diabetes in animals   Think about statins for every diabetic - group   2 tests better than 1 to diagnose diabetes in overweight children   Experts issue recommendations for treatment of post-bariatric surgery patients   Diabetes and cancer: A shared biological basis   Many Impotent Men May Have Unrecognized Diabetes   Waist size indicates risk of diabetes - study   Study may mark advance in diabetes transplant care   Ongoing relationship with care provider key for patients with a chronic condition: UBC study   Even a late exercise start cuts heart risks   Diabetics Show Alarming Increase in Morbid Obesity

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]